These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26849715)

  • 1. Thrombosis-associated antifibrinogen IgG1 κ impairs fibrin polymerization and enhances platelet activation.
    Galanakis DK; Spitzer ED; Perrotta P; Nagaswami C; Marchi R; Spitzer S; Refailovich M; Smith RE; Zhang L; Marmorat C; Weisel JW
    Blood Coagul Fibrinolysis; 2017 Jan; 28(1):40-49. PubMed ID: 26849715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.
    Muthard RW; Welsh JD; Brass LF; Diamond SL
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
    Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
    J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot.
    Marchi RC; Meyer MH; de Bosch NB; Arocha-Piñango CL; Weisel JW
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):559-67. PubMed ID: 15389122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
    Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen).
    Di Minno G; Martinez J; Cirillo F; Cerbone AM; Silver MJ; Colucci M; Margaglione M; Tauro R; Semeraro N; Quattrone A
    Arterioscler Thromb; 1991; 11(4):785-96. PubMed ID: 1829631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboelastographic phenotypes of fibrinogen and its variants: clinical and non-clinical implications.
    Galanakis DK; Neerman-Arbez M; Brennan S; Rafailovich M; Hyder L; Travlou O; Papadakis E; Manco-Johnson MJ; Henschen A; Scharrer I
    Thromb Res; 2014 Jun; 133(6):1115-23. PubMed ID: 24679643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism.
    Mullin JL; Gorkun OV; Lord ST
    Biochemistry; 2000 Aug; 39(32):9843-9. PubMed ID: 10933802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The isolation of fibrinogen monomer dramatically influences fibrin polymerization.
    Huang L; Lord ST
    Thromb Res; 2013 Jun; 131(6):e258-63. PubMed ID: 23622556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen Stony Brook, a heterozygous A alpha 16Arg----Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly.
    Galanakis DK; Henschen A; Peerschke EI; Kehl M
    J Clin Invest; 1989 Jul; 84(1):295-304. PubMed ID: 2738154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.
    Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Santos NC; Ariёns RAS
    Nanomedicine; 2018 Apr; 14(3):909-918. PubMed ID: 29410160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen naples I (B beta A68T) nonsubstrate thrombin-binding capacities.
    Meh DA; Mosesson MW; Siebenlist KR; Simpson-Haidaris PJ; Brennan SO; DiOrio JP; Thompson K; Di Minno G
    Thromb Res; 2001 Jul; 103(1):63-73. PubMed ID: 11434947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that heterodimers exist in the fibrinogen Matsumoto II (gamma308N-->K) proband and participate in fibrin fiber formation.
    Okumura N; Terasawa F; Fujita K; Fujihara N; Tozuka M; Koh CS
    Thromb Res; 2002 Aug; 107(3-4):157-62. PubMed ID: 12431483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
    Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
    J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin and fibrinogen γ' impact clot structure by marked effects on intrafibrillar structure and protofibril packing.
    Domingues MM; Macrae FL; Duval C; McPherson HR; Bridge KI; Ajjan RA; Ridger VC; Connell SD; Philippou H; Ariëns RA
    Blood; 2016 Jan; 127(4):487-95. PubMed ID: 26608329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfibrinogenemia-associated novel heterozygous mutation, Shanghai (FGA c.169_180+2 del), leads to N-terminal truncation of fibrinogen Aα chain and impairs fibrin polymerization.
    Zhou J; Ding Q; Wu W; Ouyang Q; Xie Y; Wu X; Lu Y; Dai J; Liang Q; Wang H; Wang X; Hu Y
    J Clin Pathol; 2017 Feb; 70(2):145-153. PubMed ID: 27555433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation of mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo," using gprphoresis to differentiate semifibrin molecules from fibrinogen and fibrin.
    Shainoff JR; Ratnoff OD; Smejkal GB; DiBello PM; Welches WR; Lill H; Mitkevich OV; Periman P
    Thromb Res; 2001 Jan; 101(2):91-9. PubMed ID: 11342210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.